Wnt signalling and the mechanistic basis of tumour development

被引:143
作者
Ilyas, M [1 ]
机构
[1] Gen Infirm, Acad Unit Pathol, Leeds LS1 3EX, W Yorkshire, England
关键词
Wnt signalling; beta-catenin; tumourigenesis;
D O I
10.1002/path.1692
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Abnormalities diverse signalling Wnt signalling pathway are found in a wide range of cancers. The gin of these malignancies implies that the contribution that disrupted Wnt makes to tumourigenesis is not limited to specific tissue types and thus can be regarded as a step which is 'generic' to the process of carcinogenesis. In recent years, rapid progress has been made in the understanding of the Wnt signalling pathway, giving an insight into how inappropriate activation of this pathway may facilitate the neoplastic conversion of a normal cell. Furthermore, elucidation of the mechanisms that regulate Wnt signalling has led to the possibility of manipulating these mechanisms in order to down-regulate Wnt signalling in established tumours. In this review, the Wnt signalling pathway is described. The role of aberrant Wnt signalling in tumour development is discussed together with its clinical implications for anti-tumour therapy. Copyright (C) 2005 Pathological Society of Great Britain and Ireland. Published by John Wiley Sons, Ltd.
引用
收藏
页码:130 / 144
页数:15
相关论文
共 199 条
  • [31] The integrin-linked kinase regulates the cyclin D1 gene through glycogen synthase kinase 3β and cAMP-responsive element-binding protein-dependent pathways
    D'Amico, M
    Hulit, J
    Amanatullah, DF
    Zafonte, BT
    Albanese, C
    Bouzahzah, B
    Fu, MF
    Augenlicht, LH
    Donehower, LA
    Takemaru, KI
    Moon, RT
    Davis, R
    Lisanti, MP
    Shtutman, M
    Zhurinsky, J
    Ben-Ze'ev, A
    Troussard, AA
    Dedhar, S
    Pestell, RG
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (42) : 32649 - 32657
  • [32] Dahmen RP, 2001, CANCER RES, V61, P7039
  • [33] Oncogenic mutants of RON and MET receptor tyrosine kinases cause activation of the β-catenin pathway
    Danilkovitch-Miagkova, A
    Miagkov, A
    Skeel, A
    Nakaigawa, N
    Zbar, B
    Leonard, EJ
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 2001, 21 (17) : 5857 - 5868
  • [34] Insulin and IGF-1 stimulate the β-catenin pathway through two signalling cascades involving GSK-3β inhibition and Ras activation
    Desbois-Mouthon, C
    Cadoret, A
    Blivet-Van Eggelpoël, MJ
    Bertrand, F
    Cherqui, G
    Perret, C
    Capeau, J
    [J]. ONCOGENE, 2001, 20 (02) : 252 - 259
  • [35] New functions for the matrix metalloproteinases in cancer progression
    Egeblad, M
    Werb, Z
    [J]. NATURE REVIEWS CANCER, 2002, 2 (03) : 161 - 174
  • [36] β-Catenin and TGFβ signalling cooperate to maintain a mesenchymal phenotype after FosER-induced epithelial to mesenchymal transition
    Eger, A
    Stockinger, A
    Park, J
    Langkopf, E
    Mikula, M
    Gotzmann, J
    Mikulits, W
    Beug, H
    Foisner, R
    [J]. ONCOGENE, 2004, 23 (15) : 2672 - 2680
  • [37] Nuclear localization signal-independent and importin/karyopherin-independent nuclear import of β-catenin
    Fagotto, F
    Glück, U
    Gumbiner, BM
    [J]. CURRENT BIOLOGY, 1998, 8 (04) : 181 - 190
  • [38] A GENETIC MODEL FOR COLORECTAL TUMORIGENESIS
    FEARON, ER
    VOGELSTEIN, B
    [J]. CELL, 1990, 61 (05) : 759 - 767
  • [39] Isolation and biochemical characterization of the human Dkk-1 homologue, a novel inhibitor of mammalian Wnt signaling
    Fedi, P
    Bafico, A
    Soria, AN
    Burgess, WH
    Miki, T
    Bottaro, DP
    Kraus, MH
    Aaronson, SA
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (27) : 19465 - 19472
  • [40] Fujimori M, 2001, CANCER RES, V61, P6656